Evolent Health (EVH) Tops Q2 EPS by 3c

Evolent Health (NYSE: EVH) reported Q2 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $652.52 million versus the consensus estimate of $597.46 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• RBC Capital Starts Shake Shack (SHAK) at Outperform
• ICICI Securities Starts Jain Resource Recycling (JAINREC:IN) at Buy (1)
• Barclays Downgrades Ipsen SA (IPN:FP) (IPSEF) to Underweight